怪物飲料 MNST 深 滬
等待開盤 06-25 09:30:00 美东时间
94.70
+1.010
+1.08%
華盛通- 最 高95.7458
- 今 開93.96
- 成交量 438.56万股
- 最 低 93.465
- 昨 收 93.69
- 總市值 9261.74万
- 52周最高 95.7458
- 市盈率 靜 48.93
- 換手率 0.45%
- 52周最低 58.09
- 委 比 92.82%
- 總股本 0.01亿
- 歷史最高 95.7458
- 量 比 0.69
- 振 幅 2.43%
- 歷史最低 5.7383
- 每 手 1
- 風險率 8.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Here's How Much $100 Invested In Monster Beverage 15 Years Ago Would Be Worth Today
Monster Beverage (NASDAQ:MNST) has outperformed the market over the past 15 years by 6.81% on an annualized basis producing an average annual return of 19.19%. Currently, Monster Beverage has a market capitalization of $91.00 billion. Buying $100 In MNST: If an investor had bought $100 of MNST stock...
06-23 00:00
Oppenheimer’s top buy ideas and sell ideas within each sector
Oppenheimer analysts remain constructive on the market rally, identifying beta and momentum as the two primary drivers of the advance off the March low. While critics often cite the risk of a momentum...
06-15 23:39
Stock index futures surge buoyed by U.S.-Iran peace deal
Stock index futures were sharply higher on Monday as the U.S. and Iran announced a long-awaited peace agreement that would restore shipping through the Strait of Hormuz. Nasdaq 100 futures (US100:IND)...
06-15 16:10
美股大行评级 | Adobe惨遭18家大行下调目标价！CFRA首予SpaceX(SPCX)"卖出"评级，目标价115美元
今日重点评级关注：Piper Sandler：维持Tenax Therapeutics"超配"评级，目标价从20美元升至50美元；Tigress Financial：维持优步"买入"评级，目标价从110美元升至115美元
06-15 08:32
Bernstein Initiates Coverage On Monster Beverage with Market Perform Rating, Announces Price Target of $95
Bernstein analyst Cristian Rios initiates coverage on Monster Beverage (NASDAQ:MNST) with a Market Perform rating and announces Price Target of $95.
06-12 22:53
怪物饮料股价技术形态偏强，估值偏高待Q2业绩及海外扩张验证
经济观察网 怪物饮料股价突破前期平台后延续上涨，当前估值偏高，后续走势待业绩及海外扩张情况验证。 股票近期走势 股价在突破前期平台后延续上涨趋势，目前价格运行在...
06-11 02:09
怪物饮料的国际市场繁荣：海外销售额为何达45%
怪兽饮料公司（Monster Beverage Corporation）MNST 2026年第一季度国际业务表现出色，欧洲、亚太和拉丁美洲需求强劲，海外业务营收...
06-04 01:38
美股大行评级 | 瑞杰金融上调美光目标价从530美元升至1100美元；AMD、Arm、戴尔、英特尔等获多家机构上调目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13.5美元升至14美元；BTIG：维持Jade Biosciences"买入"评级，目标价从39美元升至74美元
06-02 16:25
Morgan Stanley Maintains Overweight on Monster Beverage, Raises Price Target to $103
Morgan Stanley analyst Dara Mohsenian maintains Monster Beverage (NASDAQ:MNST) with a Overweight and raises the price target from $100 to $103.
06-01 19:33
怪物饮料餐饮渠道渗透率较低 切入连锁餐饮有望获新增长空间
经济观察网 怪物饮料旗下能量饮料餐饮渠道渗透率远低于碳酸饮料，切入连锁餐饮有望打开新的增量空间。 渠道拓展前景: 餐饮渠道被视为一个重要的潜在增长点。分析指出...
05-30 05:51
